Archives

by in
Entry Author Date Location
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Aura Bio Gets $21M, Pivots to Rare Eye Cancers With Virus Nanotech 03/05/15 Boston
“Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap 03/04/15 San Francisco
Tricida Grabs $30M Series B for Chronic Kidney Disease Treatment 03/04/15 San Francisco
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within 01/21/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA 01/08/15 Boston
Roundup: NextEnergy, Start Garden, LLamasoft, Atterocor, U-M, More 11/20/14 Detroit
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Deltanoid and Beyond: Madison Legend DeLuca Has More “D” To Play 11/17/14 Wisconsin
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
BioPontis, Reborn as Nonprofit, Takes On Rare Disease Drugs 10/20/14 Raleigh Durham
At U-M, 40 Years Of Gaucher Research Rewarded With FDA Approval 09/11/14 Detroit
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
Zurex Pharma Raises $4M to Battle Hospital-Acquired Infections 07/02/14 Wisconsin
Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study 06/14/14 Boston
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
In Need Of Revenues, Aastrom Buys Sanofi’s Cell Therapy Products 04/25/14 Detroit
Page 1 of 16 next page »